Skip to main content

TRAPHAGEN INVESTMENT ADVISORS LLC

Position in JNJ — Johnson & Johnson

CIK 2023380 ORADELL, NJ

Position in JNJ

as of Jun 30, 2026 · filed Jul 16, 2026
Position Value
$2,494,239
+$120,727 QoQ
Shares Held
9,821
+1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#2,163
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

TRAPHAGEN INVESTMENT ADVISORS LLC holds $8,468,712 across 7 Drug Manufacturers - General names. JNJ ranks #1 (29.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JNJ
Johnson & Johnson
This page
9,821 $2,494,239

All Filings in JNJ

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,494,239 9,821
2026-03-31 $2,373,512 9,710
2025-12-31 $2,062,670 9,967
2025-09-30 $1,855,312 10,006
2025-06-30 $1,673,681 10,957
2025-03-31 $1,640,655 9,893
2024-12-31 $1,477,727 10,218
2024-09-30 $1,698,874 10,483
2024-06-30 $1,522,402 10,416
2024-03-31 $1,608,475 10,168
2023-12-31 $1,601,099 10,215
2023-09-30 $1,668,082 10,710
2023-06-30 $1,646,924 9,950
2023-03-31 $1,329,280 8,576
2022-12-31 $1,442,877 8,168
2022-09-30 $1,319,785 8,079
2022-06-30 $1,457,002 8,208
2022-03-31 $1,380,444 7,789
2021-12-31 $1,421,762 8,311
2021-09-30 $1,356,277 8,398
2021-06-30 $1,348,232 8,184
2021-03-31 $1,431,488 8,710
2020-12-31 $1,393,285 8,853
2020-09-30 $11,950 50,000
2020-06-30 $1,056,412 7,512
2020-03-31 $960,527 7,325